TETON OLE RIN-PF-302. An Open-label Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
United Therapeutics Corporation
Start Date
August 29, 2025
End Date
June 14, 2030
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
United Therapeutics Corporation
Start Date
August 29, 2025
End Date
June 14, 2030